MAM
Sony ropes in seven sponsors for IPL 3
MUMBAI: Multi Screen Media (earlier Sony Entertainment Television India) has roped in seven sponsors for the third season of the Indian Premier League (IPL).
Vodafone has come in as a co-presenting sponsor and the associate sponsors are Pepsi and LG.
Indiantelevision.com had earlier reported that MSM had got Videocon as a co-presenting sponsor and Samsung and Hyundai as associate sponsors.
“We have done another deal in the associate sponsorship category but I can’t reveal further details at this stage. Sponsors are shelling out Rs 475,000 per 10-second spot,” MSM president network sales, licensing and telephony Rohit Gupta tells Indiantelevision.com.
MSM is looking at getting in three more associate sponsors. “There are several categories open like DTH and insurance. We are in talks with several companies including the likes of Havells, Godrej and Hero Honda. We have also closed three sponsorship deals for Extraa Innings. We are looking for three more in this segment,” avers Gupta.
Gupta says that sponsors will take around 60-70 per cent of the inventory. “We will look later at spot buys which will start from Rs 500,000,” he adds.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
